| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/13/2006 | CA2588644A1 Inhibition of li expression in mammalian cells |
| 07/13/2006 | CA2588026A1 Methods and compositions for rna interference |
| 07/13/2006 | CA2587697A1 Rnai modulation of the bcr-abl fusion gene and uses thereof |
| 07/12/2006 | EP1679376A2 Recombinant adenovirus comprising a chimeric penton base protein |
| 07/12/2006 | EP1679375A1 Methods and compositions for cancer therapies using genes encoding interferon-beta |
| 07/12/2006 | EP1679370A1 Method of evaluating cancerization degree |
| 07/12/2006 | EP1678497A2 Methods and compositions for modulating apoptosis |
| 07/12/2006 | EP1678311A2 Retroviral and lentiviral vectors |
| 07/12/2006 | EP1678303A2 C-class oligonucleotide analogs with enhanced immunostimulatory potency |
| 07/12/2006 | EP1678293A2 Compositions of stabilized dna for coating microprojections |
| 07/12/2006 | EP1678207A1 Regulation of matrix metalloproteinases by psp94 family members |
| 07/12/2006 | EP1678205A1 Clq RELATED PROTEIN |
| 07/12/2006 | EP1678193A1 Hepatocellular carcinoma specific promoter and uses thereof |
| 07/12/2006 | EP1677833A2 In vivo gene therapy of parkinson's disease |
| 07/12/2006 | EP1677832A1 Lentivirus vector-based approaches for generating an immune response to hiv humans |
| 07/12/2006 | EP1677831A1 Plasmid encoding fibroblast growth factor for the treatment of hypercholesterolemia or diabetes associated angiogenic defects |
| 07/12/2006 | EP1677822A2 4'-thionucleosides and oligomeric compounds |
| 07/12/2006 | EP1677735A2 Methods and compositions for modulating adipocyte function |
| 07/12/2006 | EP1349926B1 Complementing cell lines |
| 07/12/2006 | EP1254253B1 Single stranded oligonucleotides, probes, primers and method for detecting spirochetes |
| 07/12/2006 | EP1200132B1 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines |
| 07/12/2006 | EP1150570B1 Activation of regulatory t cells by alpha-melanocyte stimulating hormone |
| 07/12/2006 | EP1124950B1 Morpholino based p53 antisense oligonucleotide, and uses thereof |
| 07/12/2006 | EP1121157B1 A novel component in the hedgehog signalling pathway |
| 07/12/2006 | EP1071764B1 Antisense oligonucleotides for the inhibition of integrin alphav-subunit expression |
| 07/12/2006 | CN1800388A Eight human miRNAs |
| 07/12/2006 | CN1800387A Small interfering RNA for suppressing multiple effect growth factor expression and its uses |
| 07/12/2006 | CN1800215A Related gene and protein for preventing and treating Japanese blood fluke infection, and its uses |
| 07/12/2006 | CN1263864C Recombinant adenoviral vector and methods of use |
| 07/12/2006 | CN1263861C Compact epstein-barr virus peplicons |
| 07/12/2006 | CN1263856C Operation of enzymatic vitality of protoporphyrinogen oxidase in eukaryote |
| 07/12/2006 | CN1263854C Neisserial antigens |
| 07/12/2006 | CN1263853C Carrier system containing artificial transcription factor regulated by oxygen deficit, and its configuration and use |
| 07/12/2006 | CN1263852C Extracellular matrix signalling molecules |
| 07/12/2006 | CN1263730C Esters of L-carnitine or alkanoyl L-carnitines used as cation lipid for intracellular release pharmacological activity compound |
| 07/12/2006 | CN1263511C Live recombined vaccines injected with adjuvant |
| 07/12/2006 | CA2489780A1 Methods for preventing or treating a condition or a disease associated with angiogenesis |
| 07/11/2006 | US7074915 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof |
| 07/11/2006 | US7074909 Prevent, therapy of disease; isolated nucleic acid which codes antibody; binding to human antigen |
| 07/11/2006 | US7074904 MHC molecule that contains a peptide-binding groove, and a presenting peptide covalently linked to the MHC molecule, the fusion complex being capable of modulating the activity of a T cell. |
| 07/11/2006 | US7074901 Nucleotide sequences coding polypeptides for use in the tumor/cancer therapy |
| 07/11/2006 | US7074895 Sequences characteristic of hypoxia-regulated gene transcription |
| 07/11/2006 | US7074889 Identification of a new cytotoxic activity from the ink of Aplysia punctata |
| 07/11/2006 | US7074772 Expression vector for use in the transfer of genetic information |
| 07/11/2006 | US7074770 Administering to a mammal a vector or nucleotide sequence which code an antigenic peptide; together with Schiff base |
| 07/11/2006 | US7074769 Antisense oligonucleotide or analog thereof comprising 10 or more contiguous bases or base analogs; for treating cancer |
| 07/11/2006 | US7074617 MHC class II antigen-presenting systems and methods for activatind CD4+T cells |
| 07/11/2006 | US7074601 Nucleozymes |
| 07/11/2006 | US7074574 Method of detecting growth differentiation factor-7 (GDF-7) using GDF-7 antibodies |
| 07/11/2006 | US7074571 Serine carboxypeptidase hx (SCPhx) and compositions thereof |
| 07/11/2006 | US7074554 Methods for detecting NEBR1 expression in a biological sample by contacting a sample with the labeled antibody; inhibits HIV replication in host cells |
| 07/11/2006 | US7074432 Drug , biocompatible polymer and biphosphonate compound |
| 07/11/2006 | US7074400 Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene |
| 07/11/2006 | US7074399 Treatment of inflammation with p20 |
| 07/11/2006 | CA2198210C Non self-inactivating, expression targeted retroviral vectors |
| 07/11/2006 | CA2176463C Hu-b1.219, a novel human hematopoietin receptor |
| 07/06/2006 | WO2006072016A2 Methods for regulation of stem cells |
| 07/06/2006 | WO2006071949A2 Zebrafish heterotrimer g-protein gamma 2 subunit (gng2) |
| 07/06/2006 | WO2006071878A1 Methods and compositions for treating epithelial cancers |
| 07/06/2006 | WO2006071410A2 Apparatus and system having dry gene silencing compositions |
| 07/06/2006 | WO2006070718A1 Drugs for diseases accompanying changes in total bile acid pool or lipid metabolism disorders and method of screening these drugs |
| 07/06/2006 | WO2006070348A1 PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH NF-κB ACTIVITY |
| 07/06/2006 | WO2006047687A3 Compositions and methods for short interfering nucleic acid inhibition of nav1.8 |
| 07/06/2006 | WO2006043060A3 Mam domain containing protein |
| 07/06/2006 | WO2006043036A3 Treatment of diabetes |
| 07/06/2006 | WO2006042105A3 Promotion of cell migration and axon regeneration in the cns |
| 07/06/2006 | WO2006012625A3 Stat3 decoy oligonucleotides and uses therefor |
| 07/06/2006 | WO2005097993A3 Immunostimulatory viral rna oligonucleotides |
| 07/06/2006 | WO2005062881A3 Gene therapy using transposon-based vectors |
| 07/06/2006 | WO2004062603A3 Methods of treating lung diseases |
| 07/06/2006 | WO2004043232A3 Methods for identifying risk of melanoma and treatments thereof |
| 07/06/2006 | US20060150271 Artificial chromosomes, uses thereof and method for preparing artificial chromosomes |
| 07/06/2006 | US20060150264 Differential gene expression in schizophrenia |
| 07/06/2006 | US20060148751 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 07/06/2006 | US20060148750 Polynucleotide vaccines expressing codon optimized HIV-1 Pol and modified HIV-1 Pol |
| 07/06/2006 | US20060148749 Novel treatment of neurodegenerative diseases by altering levels of TrkB isoforms and/or TrkC isoforms |
| 07/06/2006 | US20060148748 Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met |
| 07/06/2006 | US20060148747 Antisense antiviral compound and method for treating influenza viral infection |
| 07/06/2006 | US20060148746 Nucleic acid inhibitors of glutamate receptors |
| 07/06/2006 | US20060148745 DNA-based aptamers for human cathepsin G |
| 07/06/2006 | US20060148744 Use of cis-epoxyeicosantrienoic acids and inhibitors of soluble epoxide hydrolase to reduce damage from stroke |
| 07/06/2006 | US20060148743 Controlling gene expression; anticancer agents; antiproliferative agents; mixture of nucleic acid and diluent or carrier |
| 07/06/2006 | US20060148742 Polynucleotide delivery to cardiac tissue |
| 07/06/2006 | US20060148741 Metastasis suppressor gene on human chromosome 8 and its use in the diagnosis, prognosis and treatment of cancer |
| 07/06/2006 | US20060148740 Mannose-6-phosphate receptor mediated gene transfer into muscle cells |
| 07/06/2006 | US20060148739 Method of evaluating compound efficacious in treating obesity |
| 07/06/2006 | US20060148738 Preventive for adhesion following abdominal surgery |
| 07/06/2006 | US20060148737 Wound healing method and kits |
| 07/06/2006 | US20060148736 Device for assaying polymorphisms of gene xpd/ercc2 for the correct administration of chemotherapy for lung cancer |
| 07/06/2006 | US20060148735 Methods for treating, preventing, or reducing cardiac disorders using fadd inhibitors |
| 07/06/2006 | US20060148734 Diaminoacid-aminoacid-polyamine based gemini surfactant compounds |
| 07/06/2006 | US20060148725 Selective 11beta HSD inhibitors and methods of use thereof |
| 07/06/2006 | US20060148709 Neuroprotective properties of GDF-15, a novel member of the TGF-Beta superfamily |
| 07/06/2006 | US20060148695 Novel angiogenic composition and use thereof |
| 07/06/2006 | US20060148694 Inhibition of stress-induced ligand-dependent egfr activation |
| 07/06/2006 | US20060148692 Novel protein and its dna |
| 07/06/2006 | US20060148691 Sustained release preparation for therapy of coronary stenosis or obstruction |
| 07/06/2006 | US20060148677 Chondrogenesis stimulator |
| 07/06/2006 | US20060148087 Development of a preventive vaccine for filovirus infection in primates |
| 07/06/2006 | US20060148083 Culturing whole bone marrow from mammal in medium comprising fibroblast growth factor-2 and epidermal growth factor to produce neural progenitor cell carrying gene that effects local production of biological compound, administering to tumor diseased tissue; gene therapy |